These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 16257420)

  • 21. Selective mu and delta, but not kappa, opiate receptor antagonists inhibit the habituation of novelty-induced hypoalgesia in the rat.
    Spreekmeester E; Rochford J
    Psychopharmacology (Berl); 2000 Jan; 148(1):99-105. PubMed ID: 10663423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The kappa-opioid receptor antagonist, nor-binaltorphimine (nor-BNI), decreases morphine withdrawal and the consequent conditioned place aversion in rats.
    Kelsey JE; Verhaak AM; Schierberl KC
    Behav Brain Res; 2015 Apr; 283():16-21. PubMed ID: 25591478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Coactivation of μ- and κ-Opioid Receptors May Mediate the Protective Effect of Testosterone on the Development of Temporomandibular Joint Nociception in Male Rats.
    Macedo CG; Fanton LE; Fischer L; Tambeli CH
    J Oral Facial Pain Headache; 2016; 30(1):61-7. PubMed ID: 26817034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
    Sterious SN; Walker EA
    J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
    Liu-Chen LY; Yang HH; Li S; Adams JU
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mu and kappa opioid receptor expression in the mediobasal hypothalamus and effectiveness of selective antagonists on prolactin release during lactation.
    Tavakoli-Nezhad M; Arbogast LA
    Neuroscience; 2010 Mar; 166(2):359-67. PubMed ID: 20045447
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of systemically administered nor-binaltorphimine (nor-BNI) on kappa-opioid agonists in the mouse writhing assay.
    Broadbear JH; Negus SS; Butelman ER; de Costa BR; Woods JH
    Psychopharmacology (Berl); 1994 Jul; 115(3):311-9. PubMed ID: 7871070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynorphin A1-13 causes elevation of serum levels of prolactin through an opioid receptor mechanism in humans: gender differences and implications for modulation of dopaminergic tone in the treatment of addictions.
    Kreek MJ; Schluger J; Borg L; Gunduz M; Ho A
    J Pharmacol Exp Ther; 1999 Jan; 288(1):260-9. PubMed ID: 9862779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of a mu-selective opioid antagonist on CCK-8-induced changes in thermoregulation in the rat.
    Ghosh S; Handler CM; Geller EB; Adler MW
    Pharmacol Biochem Behav; 1998 Jan; 59(1):261-4. PubMed ID: 9443564
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anoretic effects of neuropeptide FF are mediated via central mu and kappa subtypes of opioid receptors and receptor ligands.
    Cline MA; Mathews DS
    Gen Comp Endocrinol; 2008; 159(2-3):125-9. PubMed ID: 18823989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of opioid receptors in the oxytocin-induced antinociception in the central nervous system of rats.
    Gao L; Yu LC
    Regul Pept; 2004 Aug; 120(1-3):53-8. PubMed ID: 15177920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antagonism of phosphoramidon-induced antinociception in mice by mu- but not kappa-opioid receptor blockers.
    Pruhs RJ; Peña RT; Quock RM
    Life Sci; 2007 Apr; 80(19):1816-20. PubMed ID: 17379253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase-specific central regulatory systems of hibernation in Syrian hamsters.
    Tamura Y; Shintani M; Nakamura A; Monden M; Shiomi H
    Brain Res; 2005 May; 1045(1-2):88-96. PubMed ID: 15910766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agonist/antagonist properties of nalbuphine, butorphanol and (-)-pentazocine in male vs. female rats.
    Craft RM; McNiel DM
    Pharmacol Biochem Behav; 2003 Apr; 75(1):235-45. PubMed ID: 12759132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Body temperature and analgesic effects of selective mu and kappa opioid receptor agonists microdialyzed into rat brain.
    Xin L; Geller EB; Adler MW
    J Pharmacol Exp Ther; 1997 Apr; 281(1):499-507. PubMed ID: 9103537
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paradoxical hyperalgesia induced by mu-opioid receptor agonist endomorphin-2, but not endomorphin-1, microinjected into the centromedial amygdala of the rat.
    Terashvili M; Wu HE; Schwasinger E; Tseng LF
    Eur J Pharmacol; 2007 Jan; 554(2-3):137-44. PubMed ID: 17112504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression and localization of delta-, kappa-, and mu-opioid receptors in human spermatozoa and implications for sperm motility.
    Agirregoitia E; Valdivia A; Carracedo A; Casis L; Gil J; Subiran N; Ochoa C; Irazusta J
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4969-75. PubMed ID: 16984994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of CNS opioid on autonomic nervous and cardiovascular responses in diet-induced obese rats.
    Barnes MJ; Jen KL; Dunbar JC
    Peptides; 2004 Jan; 25(1):71-9. PubMed ID: 15003358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of humoral immune responses in the rat by centrally applied Met-Enk and opioid receptor antagonists: functional interactions of brain OP1, OP2 and OP3 receptors.
    Dimitrijević M; Stanojević S; Kovacević-Jovanović V; Miletić T; Vujić-Redzić V; Radulović J
    Immunopharmacology; 2000 Sep; 49(3):255-62. PubMed ID: 10996023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pentazocine-induced antinociception is mediated mainly by μ-opioid receptors and compromised by κ-opioid receptors in mice.
    Shu H; Hayashida M; Arita H; Huang W; Zhang H; An K; Wu G; Hanaoka K
    J Pharmacol Exp Ther; 2011 Aug; 338(2):579-87. PubMed ID: 21543510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.